HistoIndex Secures $9M for US Expansion and AI Pathology Tests

HistoIndex has secured a SGD9 million investment led by OCBC to expand its AI-powered digital pathology solutions in the US.

HistoIndex has secured a SGD9 million investment to support its expansion in the US, announced in a press release. The funding round was led by OCBC, marking its first investment in a medical technology company, with continued support from existing shareholders ZIG Ventures and SEEDS Capital.

The investment will focus on expanding HistoIndex-partnered laboratories and operations within the US and developing next-generation AI-powered digital pathology tests for Metabolic Dysfunction-Associated Steatohepatitis (MASH) patients. This includes the launch of FibroSIGHT™, a Laboratory Developed Test now available for order in the US, designed to provide accurate liver fibrosis assessments.

Dr. Gideon Ho, CEO of HistoIndex, stated that the investment positions the company for strategic expansion in the US and accelerates the adoption of advanced digital pathology solutions aimed at transforming MASH diagnosis and treatments.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI

AI Brief (X)

More from: Funding

DataBahn.ai Secures $17M to Enhance AI Data Pipelines

Jul 01

Waypoint AI Secures $3.1M Pre-Seed Funding for AI Customer Support

Jul 01

CRED Secures $15M to Enhance Predictive Intelligence for Enterprises

Jul 01

Movable Ink to be Acquired by STG

Jul 01

GreetEat Acquires WallStreetStats.io to Boost AI Capabilities

Jul 01

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.